6 hospitalized, one brain-dead, in French clinical drug trial

The tests were conducted in a licenced private facility.
By Ed Adamczyk  |  Jan. 15, 2016 at 10:30 AM
share with facebook
share with twitter

RENNES , France, Jan. 15 (UPI) -- Six patients participating in a clinical drug trial in France were hospitalized, one with brain damage, the French health minister said Friday.

The drug was in a Phase 1 clinical trial and being tested on healthy volunteers in a licensed private facility specializing in clinical trials, said Marisol Touraine, minister for social affairs, health and women's rights, in a statement.

No information was released about the drug other than it was administered orally.

The sickened were transported to a hospital in the northwestern French town of Rennes. One victim was declared brain-dead and in intensive care, the statement said.

Deaths or other adverse reactions in Phase 1 trials, which focus on safety and side effects and not on a medication's usefulness, are rare.

Touraine said she would travel to Rennes and said France's regulatory agency for medical devices announced it will inspect the site of the trials.

Related UPI Stories
Trending Stories